Organicell

Organicell (BPSR) a Triple Since Easter.

Slowly she turns, step-by-step. $20 million gain in market value. Spurred by FDA Emergency IND's. RELATED: Adding Organicell (BPSR)...

And Just Like That, We Have Another Double. iBio (IBIO).

$5.35 With 11 Million Shares Traded and it's Not Even 10:00!

New Report: Citius (CTXR) Trades 13 Million Shares on CoronaVirus and Candida Auris News.

Announces Mino-lok® Erdicates the Deadly and Untreatable C. Auris Bacteria.Announces License of Treatment for CoronaVirus Respiratory Failure.

Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.

CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...

European Hand Sanitizer Market Expected to Reach $9.4 Billion by 2027.

Growing at a CAGR of 38.4% during 2019–2027. The European hand sanitizer market was valued at US$ 641.7 million...
Alpex BioCleanse, Biotech Stock Review

Our Favorite Hand Sanitizer Company, Aphex BioCleanse Systems Inc., is Now Publicly Traded!

Sunset Capital Assets, Inc., (SNST), Executes and Completes Definitive Share Exchange Agreement with Aphex BioCleanse Systems Inc. Our favorite...
Aphex Biocleanse, Superbug Stock Review

Oh, No. Alcohol-Based Sanitizers Losing Effectiveness Against Superbugs.

Hospital hand sanitizers not potent enough for superbug (Science) Bacterial superbugs are becoming increasingly tolerant of alcohol, the...
Corbus Pharma, Biotech Stock Review

Adding Corbis Pharma (CRBP) $5.55 to Watch List.

Running Clinical Trials Full Steam With $46 Million Banked in Late February. Not thinly, but lightly traded. Ready,...

Aphex BioCleanse (SNST) Making Serious Headlines.

Relatively quiet for most of the year. Aphex BioCleanse, our favorite Super Bug sanitizer company, made two back-to-back announcements - signaling things...

MRSA: Can Kill Within 24 Hours. Here Are Some Basics.

RESIST THE RESISTANCE: A PRIMER ON ANTIBIOTICS & ANTIBIOTIC RESISTANCE (2013) I was going to write this week about...

Latest article

Ardelyx (ARDX) Reports First Quarter 2024 Showing $204 Million in Cash!

When we added Ardelyx (ARDX) to the Watch List in November of 2022, the market cap near $80 million. Now it's...

GeoVax to Provide Corporate Update on Tuesday May 14, 2024.

Still our favorite biotech microcap, still our favorite management team, and our favorite risk to reward idea with a $4 million market...

NovaVax (NVAX) Roars Higher, Gaining 225% a $1.2 Billion Increase, at the Blink of...

Sanofi (SNY) Announces Partnership - $500 Million Upfront, plus $700 million in Milestones with NovaVax (NVAX). And some investors say Covid is...